-
Something wrong with this record ?
Melatonin influences antioxidant homeostasis and basal metabolism in the BALB/c mouse model
M. Pohanka, H. Bandouchova, J. Pikula,
Language English Country Sweden
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23353865
Knihovny.cz E-resources
- MeSH
- Antioxidants metabolism toxicity MeSH
- Basal Metabolism drug effects physiology MeSH
- Biomarkers metabolism MeSH
- Homeostasis drug effects physiology MeSH
- Caspases metabolism MeSH
- Thiobarbituric Acid Reactive Substances metabolism MeSH
- Melatonin metabolism toxicity MeSH
- Models, Animal MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Oxidative Stress drug effects physiology MeSH
- Toxicity Tests MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: Melatonin is a hormone with strong antioxidant activity. It is biosynthesized in the pineal gland and serves in the biological signaling and control of the circadian rhythm. Though there is evidence of beneficial effects of melatonin, the substance was not investigated in greater details associated with specific regulation of oxidative stress in organs and tissues. DESIGN: The experiment is based on exposure of BALB/c mice to doses from 10 µg to 1mg of melatonin. Mice were euthanized after one and 24 hours, respectively. Biochemical markers in plasma, ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS) and activity of caspase-3 were examined in selected organs. RESULTS: We confirmed significant alteration in high-density lipoprotein and total cholesterols and glucose. After one day, levels of glucose and high-density lipoprotein cholesterol were decreased, while total cholesterol increased in a dose dependent manner. FRAP values increased in spleen, liver, kidney, heart, and brain indicating a growing potential of low molecular weight antioxidants 24 hours after exposure. However, TBARS values indicating oxidative stress were elevated in heart, kidney, and liver. CONCLUSIONS: Despite the antioxidant properties of melatonin, its effect on the organism is more complicated. It influences not only the oxidative homeostasis but also the basal metabolism, as represented by, e.g., cholesterol and glucose. This substance could thus be used for therapeutical purposes such as amelioration of pathologies associated with generation of reactive species or some metabolic dysfunctions.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13023982
- 003
- CZ-PrNML
- 005
- 20131002123230.0
- 007
- ta
- 008
- 130703s2012 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)23353865
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. miroslav.pohanka@gmail.com
- 245 10
- $a Melatonin influences antioxidant homeostasis and basal metabolism in the BALB/c mouse model / $c M. Pohanka, H. Bandouchova, J. Pikula,
- 520 9_
- $a OBJECTIVES: Melatonin is a hormone with strong antioxidant activity. It is biosynthesized in the pineal gland and serves in the biological signaling and control of the circadian rhythm. Though there is evidence of beneficial effects of melatonin, the substance was not investigated in greater details associated with specific regulation of oxidative stress in organs and tissues. DESIGN: The experiment is based on exposure of BALB/c mice to doses from 10 µg to 1mg of melatonin. Mice were euthanized after one and 24 hours, respectively. Biochemical markers in plasma, ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS) and activity of caspase-3 were examined in selected organs. RESULTS: We confirmed significant alteration in high-density lipoprotein and total cholesterols and glucose. After one day, levels of glucose and high-density lipoprotein cholesterol were decreased, while total cholesterol increased in a dose dependent manner. FRAP values increased in spleen, liver, kidney, heart, and brain indicating a growing potential of low molecular weight antioxidants 24 hours after exposure. However, TBARS values indicating oxidative stress were elevated in heart, kidney, and liver. CONCLUSIONS: Despite the antioxidant properties of melatonin, its effect on the organism is more complicated. It influences not only the oxidative homeostasis but also the basal metabolism, as represented by, e.g., cholesterol and glucose. This substance could thus be used for therapeutical purposes such as amelioration of pathologies associated with generation of reactive species or some metabolic dysfunctions.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x metabolismus $x toxicita $7 D000975
- 650 _2
- $a bazální metabolismus $x účinky léků $x fyziologie $7 D001481
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a kaspasy $x metabolismus $7 D020169
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a homeostáza $x účinky léků $x fyziologie $7 D006706
- 650 _2
- $a melatonin $x metabolismus $x toxicita $7 D008550
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a modely u zvířat $7 D023421
- 650 _2
- $a oxidační stres $x účinky léků $x fyziologie $7 D018384
- 650 _2
- $a látky reagující s kyselinou thiobarbiturovou $x metabolismus $7 D017392
- 650 _2
- $a testy toxicity $7 D018675
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bandouchova, Hana $u -
- 700 1_
- $a Pikula, Jiri $u -
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 3(2012), s. 183-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23353865 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20131002123747 $b ABA008
- 999 __
- $a ok $b bmc $g 987662 $s 822362
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 33 Suppl 3 $d 183-9 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20130703